Ductal and Acinar Differentiation in Pancreatic Endocrine Tumors

Digestive Diseases and Sciences - Tập 47 - Trang 2254-2261 - 2002
Terumi Kamisawa1, Yuyang Tu1, Naoto Egawa1, Jun-Ichi Ishiwata1, Kouji Tsuruta1, Astutake Okamoto1, Yukiko Hayashi1, Morio Koike1, Toshikazu Yamaguchi1
1Department of Internal Medicine, Tokyo Metropolitan Komagome Hospital, Bunkyo-ku, Tokyo, Japan

Tóm tắt

Rare pancreatic endocrine tumors consisting of both exocrine and endocrine components have been reported sporadically. We investigated the ductal and acinar differentiation in pancreatic endocrine tumors. In immunohistochemical studies of 28 pancreatic endocrine tumors, staining with anti-carcinoembryonic antigen (CEA) or CA19-9 antibody indicated ductal differentiation, while staining with anti-amylase or anti-trypsin antibody indicated acinar differentiation. K-ras gene mutations and p53 gene alterations also were studied. Ten tumors were immunoreactive for CEA or CA19-9. Five tumors diffusely immunoreactive for CEA or CA19-9, in addition to endocrine markers, were diagnosed as duct–endocrine cell tumors of the pancreas. Two tumors diffusely immunoreactive for CEA or CA19-9 and also for pancreaticogut hormones as well as endocrine markers were diagnosed as duct–acinar–endocrine cell tumors. These tumors showed uniform histologic features and synchronous ductal, acinar, and endocrine differentiation, distinct from the coexisting different cellular populations seen in collision tumors. All tumors were malignant. These duct–endocrine cell tumors or duct–acinar–endocrine cell tumors of the pancreas may be derived from a stem cell that retains the capability of expressing either an exocrine or endocrine phenotype. Only one K-ras gene mutation and no p53 gene alterations were detected in these tumors, which suggests that they constitute an entity with a different origin than ductal carcinomas.

Tài liệu tham khảo

Chong FK, Graham JH, Madoff IM: Mucin producing carcinoid (“composite tumor”) of upper third of esophagus: a variant of carcinoid tumor. Cancer 44:1853–1859, 1979 Gould VE, Jao W, Chejfec G, Banner BF, Bonomi P: Neuroendocrine carcinomas of the gastrointestinal tract. Semin in Diagn Pathol 1:13–18, 1984 Soga J, Tazawa K, Aizawa O, Wada K, Tutu T: Argentaffin cell adenocarcinoma of the stomach: an atypical carcinoid? Cancer 33:999–1003, 1971 Bates HR, Belter LF: Composite carcinoid tumor (argentaffinoma-adenocarcinoma) of the colon. Dis Colon Rectum 10:467–470, 1967 Lyss AP, Thompson JJ, Gluck JH: Adenocarcinoid tumor of the colon arising in preexisting ulcerative colitis. Cancer 48:833–839, 1981 Cooper PH, Warkei RL: Ultrastructure of the goblet cell type of adenocarcinoid of the appendix. Cancer 42:2687–2695, 1978 Isaacson P: Crypt cell carcinoma of the appendix (so-called adenocarcinoid tumor). Am J Surg Pathol 5:213–224, 1981 Azzopardi JG, Pollock DJ: Argentaffin and argyrophil cells in gastric carcinoma. J Pathol Bacteriol 86:443–451, 1963 Ulich TR, Cheng L, Glover H, Yang K, Lewin KJ: A colonic adenocarcinoma with argentaffin calls: an immunoperoxidase study demonstrating the presence of numerous neuroendocrine products. Cancer 51:1483–1489, 1983 Klappenbach RS, Kurman RJ, Sinclair CF, James LP: Composite carcinoma-carcinoid tumors of the gastrointestinal tract: a morphologic, histochemical, and immunohistochemical study. Am J Clin Pathol 84:137–143, 1985 Kamisawa T, Fukayama M, Tabata I, Isawa T, Tsuruta K, Okamoto A, Koike M: Neuroendocrine differentiation in pancreatic duct carcinoma: special emphasis on duct-endocrine cell carcinoma of the pancreas. Path Res Pract 192:901–908, 1996 Kamisawa T, Fukayama M, Koike M, Tabata I, Okamoto A: A case of malignant cystic endocrine tumor of the pancreas. Am J Gastroenterol 82:86–89, 1987 Kamisawa T, Fukayama M, Koike M, Tabata I, Egawa N, Isawa T, Okamoto A, Hayashi Y: Carcinoma of the ampulla of Vater: expression of cancer-associated antigens inversely correlated with prognosis. Am J Gastroenterol 83:1118–1123, 1988 Brunetto MR, Randone A, Ranki M, Jalanko A, Piantino P, Giarin M, Capra G, Calvo PL, Pliveri F, Bonino F: Quantitative analysis of wild-type and HBeAg minus hepapitis B viruses by a sequence-dependent primer extension assay. J Med Virol 43:310–315, 1994 Mihas AA, Ceballos R, Mihas A, Gibson RG: Zollinger-Ellison syndrome associated with ductal adenocarcinoma of the pancreas. N Engl I Med 298:144–146, 1978 Tomita T, Bhatia P, Gourley W: Mucin producing islet cell adenoma. Hum Pathol 12:850–853, 1981 Eusebi V, Capella C, Bondi A, Sessa F, Vezzadini P, Mancini AM: Endocrine-paracrine cells in pancreatic exocrine carcinomas. Histopathology 5:599–613, 1981 Reid JD, Yuh S-L, Petrellli M, Jaffe R: Ductuloinsular tumors of the pancreas: a light, electron microscopic and immunohistochemical study. Cancer 49:908–915, 1982 Ordonez NG, Balsaver AM, Mackay B: Mucinous islet cell (amphicrine) carcinoma of the pancreas associated with watery diarrhea and hypokalemia syndrome. Hum Pathol 19:1458–1461, 1988 Kniffin WD, Spencer SK, Memoli VA, LeMarbre PJ: Metastatic islet cell amphicrine carcinoma of the pancreas: association with an eosinophilic infiltration of the skin. Cancer 62:1999–2004, 1988 Kashiwabara K, Nakajima T, Shinkai H, Fukuda T, Oono Y, Kurabayashi Y, Kojima T, Nagamachi Y: A case of malignant duct-islet cell tumor of the pancreas: immunohistochemical and cytofluorometric study. Acta Pathol Jpn 41:636–641, 1991 Arihiro K, Inai K: Malignant islet cell tumor of the pancreas with multiple hormone production and expression of CEA and CA19-9: report of an autopsy case. Acta Pathol Jpn 41:150–157, 1991 Ulich T, Cheng L, Lewin KJ: Acinar-endocrine cell tumor of the pancreas: report of a pancreatic tumor containing both zymogen and neuroendocrine granules. Cancer 50:2099–2105, 1982 Schron DS, Mendelsohn G: Pancreatic carcinoma with duct, endocrine, and acinar differentiation: a histologic, immunohistochemical, and ultrastructural study. Cancer 54:1766–1770, 1984 Chejfec G, Capella C, Solcia E, Jao W, Gould VE: Amphicrine cells, dysplasias, and neoplasias. Cancer 56:2683–2690, 1985 Nonomura A, Kono N, Mizukami Y, Nakanuma Y, Matsubara F: Duct-acinar-islet cell tumor of the pancreas. Ultrastruct Pathol 16:317–329, 1992 Hassan MO, Gogata PA: Malignant mixed exocrine-endocrine tumor of the pancreas with unusual intracytoplasmic inclusions. Ultrastruct Pathol 17:483–493, 1993 Klimstra DS, Rosai J, Heffess CS: Mixed acinar-endocrine carcinomas of the pancreas. Am J Surg Pathol 18:765–778, 1994 Okada Y, Mori H, Tsutsumi A: Duct-acinar-islet cell tumor of the pancreas. Pathol Int 45:669–676, 1995 Shimoike T, Goto M, Nakano I, Sato T, Migita Y, Ito T, Yanase T, Sezai S, Suzuki T, Nawata H: Acinar-islet cell carcinoma presenting as insulinoma. J Gastroenterol 32:830–835, 1997 Armed Forces Institute of Pathology: Tumors of the exocrine pancreas. In Tumors of Pancreas. J Rosai, LH Sobin (eds). Washington, DC, AFIP, 1997, pp 31–144 World Health Organization: Epithelial tumors. In Histological Classification of Tumours of the Exocrine Pancreas, Berlin, Springer, 1996, pp 11–21 Kerr-Conte J, Pattou F, Lecomte-Houcke M, Xia Y, Boilly B, Proye C, Lefebvre J: Ductal cyst formation in collagenembedded adult human islet preparations. A means to the reproduction of nesidioblastosis in vitro. Diabetes 45:1108–1114, 1996 Bouwen L, Blay ED: Islet morphogenesis and stem cell markers in rat pancreas. J Histochem Cytochem 44:947–951, 1996 Yuan S, Rosenberg L, Paraskevas S, Agapitos D, Duguid WP: Transdifferentiation of human islets to pancreatic ductal cells in collagen matrix culture. Differentiation 61:67–75, 1996 Bouwens L, Lu WD, Krijger RD: Proliferation and differentiation in the human fetal endocrine pancreas. Diabetologia 40:398–404, 1997 Pour PM, Schmied B: The link between exocrine pancreatic cancer and the endocrine pancreas. Int J Pancreatol 25:77–87, 1999 Hruban RH, Mansfeld ADM, Offerhaus GJA, Weering DHJ, Allison DC, Goodman SN, Kencler TW, Bose KK, Cameron JL, Bos JL: K-ras oncogene activation in adenocarcinoma of the human pancreas: a study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 143:545–554, 1993 Scarpa A, Capelli P, Mukai K, Zamboni G, Oda T, Iacono C, Hirohashi S: Pancreatic adenocarcinomas frequently show p53 gene mutations. Am J Pathol 142:1534–1543, 1993 Yashiro T, Fulton N, Hara H, Yasuda K, Montag A, Yashiro N, Straus RN, Ito K, Aiyoshi Y, Kaplan EL: Comparison of mutations of ras oncogene in human pancreatic exocrine and endocrine tumors. Surgery 114:758–764, 1993 Pellegata NS, Sessa F, Renault B, Bonato M, Leone BE, Solcia E, Ranzani GN: K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Res 54:1556–1560, 1994 Hoorens A, Lemonine NR, McLellan E, Morohoshi T, Kamisawa T, Heits PU, Stamm B, Ruschoff J, Wiedenmann B, Kloppel G: Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation. Am J Pathol 143:685–698, 1993